Syra Health Reports Q3 Revenue Growth and Reduced Net Loss

Reuters

2025/11/12

Syra Health Reports Q3 Revenue Growth and Reduced Net Loss

Syra Health Corp. announced its financial results for the third quarter ended September 30, 2025. The company reported Q3 2025 revenue of $1.7 million, with its Population Health business unit growing 96% year-over-year to $1,280,011, compared to $652,298 in Q3 2024. Gross margin improved by 300 basis points to 33%, up from 30% in the prior year period, attributed to a strategic focus on higher-margin business units and deprioritization of lower-margin healthcare workforce contracts. Net loss for the quarter declined by 46% to ($225,902), compared to ($417,535) in Q3 2024, due to improved operational efficiency. Earnings per share improved to ($0.02) in Q3 2025 from ($0.6) in Q3 2024. The company also highlighted the launch of its SyraBot product with a managed care organization serving 400,000 members and noted ongoing growth in its sales pipeline.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syra Health Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: DE21406) on November 12, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2582795233"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2582795233\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2582795233?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-12 20:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2582795233","market":"us","top_or_hot":-1,"title":"Syra Health Reports Q3 Revenue Growth and Reduced Net Loss","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Syra Health Reports Q3 Revenue Growth and Reduced Net Loss\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/SYRA\">Syra Health Corp.</a> announced its financial results for the third quarter ended September 30, 2025. The company reported Q3 2025 revenue of $1.7 million, with its <a href=\"https://laohu8.com/S/PHIC\">Population Health</a> business unit growing 96% year-over-year to $1,280,011, compared to $652,298 in Q3 2024. Gross margin improved by 300 basis points to 33%, up from 30% in the prior year period, attributed to a strategic focus on higher-margin business units and deprioritization of lower-margin healthcare workforce contracts. Net loss for the quarter declined by 46% to ($225,902), compared to ($417,535) in Q3 2024, due to improved operational efficiency. Earnings per share improved to ($0.02) in Q3 2025 from ($0.6) in Q3 2024. The company also highlighted the launch of its SyraBot product with a managed care organization serving 400,000 members and noted ongoing growth in its sales pipeline.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syra Health Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: DE21406) on November 12, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Syra Health Reports Q3 Revenue Growth and Reduced Net Loss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSyra Health Reports Q3 Revenue Growth and Reduced Net Loss\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-12 20:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Syra Health Reports Q3 Revenue Growth and Reduced Net Loss\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/SYRA\">Syra Health Corp.</a> announced its financial results for the third quarter ended September 30, 2025. The company reported Q3 2025 revenue of $1.7 million, with its <a href=\"https://laohu8.com/S/PHIC\">Population Health</a> business unit growing 96% year-over-year to $1,280,011, compared to $652,298 in Q3 2024. Gross margin improved by 300 basis points to 33%, up from 30% in the prior year period, attributed to a strategic focus on higher-margin business units and deprioritization of lower-margin healthcare workforce contracts. Net loss for the quarter declined by 46% to ($225,902), compared to ($417,535) in Q3 2024, due to improved operational efficiency. Earnings per share improved to ($0.02) in Q3 2025 from ($0.6) in Q3 2024. The company also highlighted the launch of its SyraBot product with a managed care organization serving 400,000 members and noted ongoing growth in its sales pipeline.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syra Health Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: DE21406) on November 12, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4196","symbol_name":"保健护理服务","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL2pP1gt:1","article_id":"2582795233","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2582795233","pubTimestamp":1762952134,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Syra Health Corp. announced its financial results for the third quarter ended September 30, 2025. The company reported Q3 2025 revenue of $1.7 million, with its Population Health business unit growing 96% year-over-year to $1,280,011, compared to $652,298 in Q3 2024. Gross margin improved by 300 basis points to 33%, up from 30% in the prior year period, attributed to a strategic focus on higher-margin business units and deprioritization of lower-margin healthcare workforce contracts. Net loss for the quarter declined by 46% to , compared to  in Q3 2024, due to improved operational efficiency. Earnings per share improved to  in Q3 2025 from  in Q3 2024. The company also highlighted the launch of its SyraBot product with a managed care organization serving 400,000 members and noted ongoing growth in its sales pipeline.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4196":"保健护理服务","SYRA":"Syra Health Corp."},"translate_title":"Syra Health报告第三季度收入增长并减少净亏损","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SYRA":0.9},"content_text":"Syra Health Reports Q3 Revenue Growth and Reduced Net Loss\n    \n\nSyra Health Corp. announced its financial results for the third quarter ended September 30, 2025. The company reported Q3 2025 revenue of $1.7 million, with its Population Health business unit growing 96% year-over-year to $1,280,011, compared to $652,298 in Q3 2024. Gross margin improved by 300 basis points to 33%, up from 30% in the prior year period, attributed to a strategic focus on higher-margin business units and deprioritization of lower-margin healthcare workforce contracts. Net loss for the quarter declined by 46% to ($225,902), compared to ($417,535) in Q3 2024, due to improved operational efficiency. Earnings per share improved to ($0.02) in Q3 2025 from ($0.6) in Q3 2024. The company also highlighted the launch of its SyraBot product with a managed care organization serving 400,000 members and noted ongoing growth in its sales pipeline.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syra Health Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: DE21406) on November 12, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}